Last reviewed · How we verify
Dimethyl Fumarate Enteric-coated Capsules — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dimethyl Fumarate Enteric-coated Capsules (Dimethyl Fumarate Enteric-coated Capsules) — Nanjing Medical University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dimethyl Fumarate Enteric-coated Capsules TARGET | Dimethyl Fumarate Enteric-coated Capsules | Nanjing Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dimethyl Fumarate Enteric-coated Capsules CI watch — RSS
- Dimethyl Fumarate Enteric-coated Capsules CI watch — Atom
- Dimethyl Fumarate Enteric-coated Capsules CI watch — JSON
- Dimethyl Fumarate Enteric-coated Capsules alone — RSS
Cite this brief
Drug Landscape (2026). Dimethyl Fumarate Enteric-coated Capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/dimethyl-fumarate-enteric-coated-capsules. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab